Patents by Inventor Trevor Charvat

Trevor Charvat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRIAZOLYL PHENYL BENZENESULFONAMIDES
    Publication number: 20080039465
    Abstract: Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists and as controls in assays for the identification of CCR9 antagonists.
    Type: Application
    Filed: July 10, 2007
    Publication date: February 14, 2008
    Inventors: Trevor Charvat, Cheng Hu, Anita Melikian, Aaron Novack, Andrew Pennell, Sreenivas Punna, Edward Sullivan, Xuefei Tan, William Thomas, Solomon Ungashe, Yibin Zeng
  • TRIAZOLYL PYRIDYL BENZENESULFONAMIDES
    Publication number: 20080039504
    Abstract: Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists and as controls in assays for the identification of CCR9 antagonists.
    Type: Application
    Filed: July 10, 2007
    Publication date: February 14, 2008
    Inventors: Trevor Charvat, Cheng Hu, Jeff Jin, Yandong Li, Anita Melikian, Andrew Pennell, Sreenivas Punna, Solomon Ungashe, Yibin Zeng
  • Heteroaryl sulfonamides and CCR2
    Publication number: 20070037794
    Abstract: Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists.
    Type: Application
    Filed: July 14, 2006
    Publication date: February 15, 2007
    Inventors: Solomon Ungashe, Zheng Wei, Arindrajit Basak, Trevor Charvat, Wei Chen, Jeff Jin, Jimmie Moore, Yibin Zeng, Sreenivas Punna, Daniel Dairaghi, Derek Hansen, Andrew Pennell, John Wright
  • Heteroaryl sulfonamides and CCR2
    Publication number: 20060173019
    Abstract: Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists.
    Type: Application
    Filed: January 13, 2006
    Publication date: August 3, 2006
    Inventors: Solomon Ungashe, Zheng Wei, Arindrajit Basak, Trevor Charvat, Jeff Jin, Jimmie Moore, Yibin Zang, Sreenivas Punna, Daniel Dairaghi, Derek Hansen, Andrew Pennell, John Wright